Page last updated: 2024-11-02

papaverine and Anxiety Disorders

papaverine has been researched along with Anxiety Disorders in 2 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Anxiety Disorders: Persistent and disabling ANXIETY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nelson, JJ1
De Maio, D1

Trials

1 trial available for papaverine and Anxiety Disorders

ArticleYear
Relieving select symptoms of the elderly.
    Geriatrics, 1975, Volume: 30, Issue:3

    Topics: Age Factors; Aged; Anxiety Disorders; Attitude; Brain; Clinical Trials as Topic; Dementia; Dihydroer

1975

Other Studies

1 other study available for papaverine and Anxiety Disorders

ArticleYear
[Clinico-theoretical considerations on the association of trifluoperazine and coronary vasoactive drugs in the treatment of anxiety states in aged cardiopathic patients].
    La Clinica terapeutica, 1969, Dec-31, Volume: 51, Issue:6

    Topics: Anxiety; Anxiety Disorders; Heart Diseases; Humans; Papaverine; Pentaerythritol Tetranitrate; Phenot

1969